Worried about saying the wrong thing when talking about neurodiversity? This guide breaks down the basics: what to say, what ...

One of the vaccines for a specific strain of an avian virus could come from a research lab on the campus of South Dakota ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

In the subset of patients whose tumors expressed PD-L1 (combined positive score [CPS] ≥10), median progression-free survival (PFS ... heterozygosity (LOH)-low subgroup of participants who ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer’ s-related dementia in people ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

Recent research provides more support for the existence of long-term COVID and delves into potential causes and effects of ...

The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer's disease, which posits that the ...

Stein, MD, professor and co-director of the Acute Leukemia Program at City of Hope in Duarte, California, provides deeper insight into the trial design and key findings in an interview with Targeted ...